Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saif Huda

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Practical Neurology|December 1, 2018
Rituximab in neurological disease: principles, evidence and practiceDaniel H Whittam, Emma C Tallantyre, Stephen Jolles, et al.
BMJ Open|December 1, 2021
Predictors of relapse in MOG antibody associated disease: a cohort studySaif Huda, Daniel Whittam, Richard Jackson, et al.
European Journal of Neurology|June 10, 2025
Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United KingdomDaniel Engels, Chiara Rocchi, Mirasol Forcadela, et al.
Journal of Neurology|July 27, 2024
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypesGiovanna S Manzano, Michael Levy, Rebecca Salky, et al.
JAMA Neurology|April 21, 2015
Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia GravisPedro M Rodríguez Cruz, Michal Al-Hajjar, Saif Huda, et al.
Multiple Sclerosis and Related Disorders|January 26, 2024
Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort studyDaniel Lordelo San Martin, Thiago Gonçalves Fukuda, Thiago Santos Nascimento, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 20, 2017
IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MGSaif Huda, Patrick Waters, Mark Woodhall, et al.
Multiple Sclerosis and Related Disorders|August 16, 2024
Study of seasonality of attacks in MOG antibody-associated diseaseAnna Francis, Monica Santos, Miguel Leal Rato, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2021
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disordersValentina Camera, Silvia Messina, Kariem Tarek Elhadd, et al.
Annals of the New York Academy of Sciences|January 30, 2018
Serological and experimental studies in different forms of myasthenia gravisAngela Vincent, Saif Huda, Michelangelo Cao, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Practical Neurology|December 1, 2018
Rituximab in neurological disease: principles, evidence and practiceDaniel H Whittam, Emma C Tallantyre, Stephen Jolles, et al.
BMJ Open|December 1, 2021
Predictors of relapse in MOG antibody associated disease: a cohort studySaif Huda, Daniel Whittam, Richard Jackson, et al.
European Journal of Neurology|June 10, 2025
Rituximab as First-Line Compared to Escalation Immunotherapy Is Associated With Lower Disability Accumulation in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Cohort Study From Germany and the United KingdomDaniel Engels, Chiara Rocchi, Mirasol Forcadela, et al.
Journal of Neurology|July 27, 2024
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypesGiovanna S Manzano, Michael Levy, Rebecca Salky, et al.
JAMA Neurology|April 21, 2015
Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia GravisPedro M Rodríguez Cruz, Michal Al-Hajjar, Saif Huda, et al.
Multiple Sclerosis and Related Disorders|January 26, 2024
Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort studyDaniel Lordelo San Martin, Thiago Gonçalves Fukuda, Thiago Santos Nascimento, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 20, 2017
IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MGSaif Huda, Patrick Waters, Mark Woodhall, et al.
Multiple Sclerosis and Related Disorders|August 16, 2024
Study of seasonality of attacks in MOG antibody-associated diseaseAnna Francis, Monica Santos, Miguel Leal Rato, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2021
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disordersValentina Camera, Silvia Messina, Kariem Tarek Elhadd, et al.
Annals of the New York Academy of Sciences|January 30, 2018
Serological and experimental studies in different forms of myasthenia gravisAngela Vincent, Saif Huda, Michelangelo Cao, et al.
Pageof 8